MetLife Investment Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $24M | Buy |
|
|||||
|
2025
Q2 | $19.2M | Buy |
|
|||||
|
2025
Q1 | $20.9M | Buy |
|
|||||
|
2024
Q4 | $1.88M | Buy |
|
|||||
|
2024
Q3 | $1.89M | Hold |
|
|||||
|
2024
Q2 | $1.69M | Buy |
|
|||||
|
2024
Q1 | $1.48M | Hold |
|
|||||
|
2023
Q4 | $1.47M | Hold |
|
|||||
|
2023
Q3 | $1.29M | Buy |
|
|||||
|
2023
Q2 | $1.24M | Buy |
|
|||||
|
2023
Q1 | $1.04M | Hold |
|
|||||
|
2022
Q4 | $1.3M | Buy |
|
|||||
|
2022
Q3 | $729K | Sell |
|
|||||
|
2022
Q2 | $664K | Hold |
|
|||||
|
2022
Q1 | $718K | Buy |
|
|||||
|
2021
Q4 | $412K | Hold |
|
|||||
|
2021
Q3 | $360K | Hold |
|
|||||
|
2021
Q2 | $736K | Hold |
|
|||||
|
2021
Q1 | $618K | Hold |
|
|||||
|
2020
Q4 | $889K | Sell |
|
|||||
|
2020
Q3 | $877K | Hold |
|
|||||
|
2020
Q2 | $1.01M | Buy |
|
|||||
|
2020
Q1 | $684K | Buy |
|
|||||
|
2019
Q4 | $1.1M | Sell |
|
|||||
|
2019
Q3 | $237K | Hold |
|
|||||
|
2019
Q2 | $301K | Buy |
|